Martin Clodi
Biographic Data
| ID | 7924646 |
|---|---|
| NAME | Martin Clodi |
| GIVEN NAMES | Martin |
| FAMILY NAME | Clodi |
| SIGNATURE | CLODI M |
| AFFILIATIONS | Johannes Kepler University of Linz |
| ORCID | 0000-0003-2177-0891 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
High Anti-CoV2S Antibody Levels at Hospitalization Are Associated with Improved Survival in Patients with Covid-19 Vaccine Breakthrough Infection
In this retrospective data analysis, we show that almost all patients who died from COVID-19 vaccine breakthrough infection had antibody levels < 600 U/mL, most of them below 200 U/mL. In logistic regression corrected for the number of comorbidities and age, anti-CoV2S antibody levels at the time of hospitalization proved to be a significantly protective predictor against death
No prominent works on this page.
High Anti-CoV2S Antibody Levels at Hospitalization Are Associated with Improved Survival in Patients with Covid-19 Vaccine Breakthrough Infection
In this retrospective data analysis, we show that almost all patients who died from COVID-19 vaccine breakthrough infection had antibody levels < 600 U/mL, most of them below 200 U/mL. In logistic regression corrected for the number of comorbidities and age, anti-CoV2S antibody levels at the time of hospitalization proved to be a significantly protective predictor against death
2019-20 coronavirus outbreak (1 work) · Antibody (1 work) · Coronavirus disease 2019 (COVID-19 (1 work) · COVID-19 Clinical Research Studies (1 work) · Disease (1 work) · Immunology (1 work) · Infectious disease (medical specialty (1 work) · Internal Medicine (1 work) · Long-Term Effects of COVID-19 (1 work) · Medicine (1 work)